EUVIMEDEUVIMED entdecken
Crossref

Comorbidity Burden and Biologic Access in an Uninsured Psoriasis Population: A 20‐Year Descriptive Study

Simonetta I Gaumond iD, Sammya Mufarrej, Anna M Angioli, Rama Abdin, Victoria Billero, Franco Rongioletti, Cynthia Levy, Eduardo De Marchena, Paolo Romanelli

International Journal of Dermatology · 2026-12 · 65 (12) · 2509-2514

DOI: 10.1111/ijd.70306 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Dermatology, online erschienen am 29.01.2026. Verfasst von Simonetta I Gaumond und 8 weiteren Autor:innen. Beteiligte Einrichtung: Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA. Hauptthemen laut MEDLINE: Psoriasis, Medically Uninsured, Health Services Accessibility, Biological Products. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Psoriasis is a chronic immune‐mediated disease associated with multiple systemic comorbidities. Biologic therapies have transformed the management of moderate‐to‐severe psoriasis; however, their high cost remains a major barrier for uninsured and socioeconomically disadvantaged individuals. The Psoriasis Biologics Center for Indigent Patients at Jackson Memorial Hospital provides a structured dermatology access model for underserved populations.

Methods

We conducted a descriptive retrospective cohort study of patients with moderate‐to‐severe psoriasis receiving biologic therapy through a dedicated safety‐net access program between 2005 and 2025. Patient demographics, comorbidities, and management strategies were obtained from electronic medical records and standardized intake questionnaires. Only descriptive statistics were performed; standardized disease severity and quality‐of‐life measures such as the Psoriasis Area and Severity Index (PASI) or the Dermatology Life Quality Index (DLQI) were not available.

Results

A total of 450 patients (mean age 52.6 years; 54% female) were included. Nearly half (49.8%) presented with at least one systemic comorbidity. The most common were psoriatic arthritis (35.1%), hypertension (31.3%), diabetes mellitus (20%), cardiovascular disease (19.1%), obesity (13.8%), and dyslipidemia (12.2%). Psychiatric comorbidities included depression (9.6%) and anxiety (3.8%). Infectious conditions occurred at higher‐than‐expected frequencies, including hepatitis B/C (3.8%), latent tuberculosis (3.6%), and human immunodeficiency virus (HIV) (2.7%). Care delivery was organized within a structured safety‐net model that incorporated standardized screening protocols, referral pathways, and multidisciplinary coordination to support biological access for uninsured patients.

Conclusions

This 20‐year descriptive cohort characterizes comorbidity burden and biologic access within an indigent psoriasis population. This study does not assess clinical outcomes or treatment effectiveness. These findings describe a care delivery framework that may inform future health system and health equity‐focused initiatives.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PsoriasisMedically UninsuredHealth Services AccessibilityBiological ProductsHumansFemaleMiddle AgedMaleRetrospective StudiesComorbidityAdultSeverity of Illness IndexSafety-net ProvidersDiabetes MellitusQuality of LifeObesityAgedCardiovascular DiseasesDyslipidemiasArthritis, PsoriaticHypertension

Stichwörter der Autor:innen

HIVarthritisbiologicscardiovascularcomorbiditiesdiabetesdyslipidemiahepatitispsoriasistuberculosis

Substanzen

Biological Products

Autor:innen und Institutionen

  • Dr. Phillip Frost Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Department of Biochemistry and Molecular Biology, University of Miami Miller School of Medicine, Miami, Florida, USA.
  • Università Campus Biomédico di Roma, Rome, Italy.
  • Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida, USA.
  • Unit of Clinic Dermatology, Vita-Salute San Raffaele University, Milan, Italy.
  • Schiff Center for Liver Diseases, University of Miami Miller School of Medicine, Miami, Florida, USA.

ORCID-Profile: Simonetta I Gaumond

Zitieren

APA

Gaumond, S. I., Mufarrej, S., Angioli, A. M., Abdin, R., Billero, V., Rongioletti, F., Levy, C., De Marchena, E., & Romanelli, P. (2026). Comorbidity Burden and Biologic Access in an Uninsured Psoriasis Population: A 20‐Year Descriptive Study. International Journal of Dermatology, 65(12), 2509-2514. https://doi.org/10.1111/ijd.70306

Vancouver

Gaumond SI, Mufarrej S, Angioli AM, Abdin R, Billero V, Rongioletti F, et al. Comorbidity Burden and Biologic Access in an Uninsured Psoriasis Population: A 20‐Year Descriptive Study. International Journal of Dermatology. 2026;65(12):2509-2514. doi:10.1111/ijd.70306

BibTeX
@article{Gaumond2026,
  author = {Gaumond, Simonetta I and Mufarrej, Sammya and Angioli, Anna M and Abdin, Rama and Billero, Victoria and Rongioletti, Franco and Levy, Cynthia and De Marchena, Eduardo and Romanelli, Paolo},
  title = {Comorbidity Burden and Biologic Access in an Uninsured Psoriasis Population: A 20‐Year Descriptive Study},
  journal = {International Journal of Dermatology},
  year = {2026},
  volume = {65},
  number = {12},
  pages = {2509--2514},
  doi = {10.1111/ijd.70306}
}
Kostenlos starten →